TROY KEPPER: Open Payments
NPI 1225547599 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,072 in 248 payments from 24 companies in 2025. Trend: 2023 $4,212 · 2024 $5,534 · 2025 $6,072
Food & beverage: $5,872Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $892 |
| Alnylam Pharmaceuticals Inc. | 24 | $690 |
| Novartis Pharmaceuticals Corporation | 34 | $499 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $431 |
| E.R. Squibb & Sons, L.L.C. | 31 | $416 |
| Actelion Pharmaceuticals US, Inc. | 14 | $356 |
| United Therapeutics Corporation | 10 | $286 |
| CVRx, Inc. | 10 | $285 |
| AOP Health US, LLC | 1 | $280 |
| PFIZER INC. | 17 | $262 |
Products named: LEQVIO, AMVUTTRA, UPTRAVI, WAINUA, Barostim Neo System, Rapiblyk, CAMZYOS, Assure WCD.
Industry payments across FL — which companies pay providers there.
